60 day FRN

28356

Federal Register / Vol. 86, No. 100 / Wednesday, May 26, 2021 / Notices

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–21–1102; Docket No. CDC–2021–
0050]

Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:

The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled Tuberculosis Data from Panel
Physicians. This study collects
Tuberculosis data gathered during
overseas immigration medical exams.
DATES: Written comments must be
received on or before July 26, 2021.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2021–
0050 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS–D74, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS–
D74, Atlanta, Georgia 30329; phone:
404–639–7118; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
SUMMARY:

VerDate Sep<11>2014

20:00 May 25, 2021

Jkt 253001

must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected;
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses; and
5. Assess information collection costs.
Proposed Project
Information Collection for
Tuberculosis Data from Panel
Physicians (OMB Control No. 0920–
1102, Exp. 9/30/2021)—Revision—
National Center for Emerging and
Zoonotic Infectious Diseases (NCEZID),
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
The Centers for Disease Control and
Prevention’s (CDC), National Center for
Emerging and Zoonotic Infectious
Diseases (NCEZID), Division of Global
Migration and Quarantine (DGMQ),
Immigrant, Refugee, and Migrant Health
Branch (IRMH), requests approval for a
Revision of an existing information
collection. This project pertains to
collecting annual reports on certain
tuberculosis data from U.S. panel
physicians.
The respondents are panel physicians.
More than 760 panel physicians from

PO 00000

Frm 00028

Fmt 4703

Sfmt 4703

336 panel sites perform overseas predeparture medical examinations in
accordance with requirements, referred
to as technical instructions, provided by
DGMQs Quality Assessment Program
(QAP). The role of QAP is to assist and
guide panel physicians in the
implementation of the technical
instructions; evaluate the quality of the
overseas medical examination for U.S.bound immigrants and refugees; assess
potential panel physician sites; and
provide recommendations to the U.S.
Department of State in matters of
immigrant medical screening.
To achieve DGMQ’s mission, IRMH
works with domestic and international
programs to improve the health of U.S.bound immigrants and refugees to
protect the U.S. public by preventing
the importation of infectious disease.
These goals are accomplished through
IRMH’s oversight of medical exams
required for all U.S.-bound immigrants
and refugees who seek permanent
residence in the U.S. IRMH is
responsible for assisting and training the
international panel physicians with the
implementation of medical exam
Technical Instructions (TI). Technical
Instructions are detailed requirements
and national policies regarding the
medical screening and treatment of all
U.S.-bound immigrants and refugees.
Screening for tuberculosis (TB) is a
particularly important component of the
immigration medical exam and allows
panel physicians to diagnose active TB
disease prior to arrival in the United
States. As part of the TI requirements,
panel physicians perform chest x-rays
and laboratory tests that aid in the
identification of TB infection (Class B1
applicants) and diagnosis of active TB
disease (Class A, inadmissible
applicants). CDC uses these
classifications to report new immigrant
and refugee arrivals with a higher risk
of developing TB disease to U.S. state
and local health departments for further
follow-up. Some information that panel
physicians collect as part of the medical
exam is not reported on the standard
Department of State forms (DS-forms),
thereby preventing CDC from evaluating
TB trends in globally mobile
populations and monitoring program
effectiveness.
Currently, CDC is requesting this data
be sent by panel physicians once per
year. The consequences of reducing this
frequency would be the loss of
monitoring program impact and TB
burdens in mobile populations, and
immigrants and refugees coming to the
United States on an annual basis. The
total burden hours requested is 999.
There is no cost to the respondents
other than their time.

E:\FR\FM\26MYN1.SGM

26MYN1

28357

Federal Register / Vol. 86, No. 100 / Wednesday, May 26, 2021 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Average
burden per
response
(in hours)

Number of
responses per
respondent

Number of
respondents

Total burden
(in hours)

Type of respondents

Form name

International Panel Physicians ..........

TB Indicators REDCap web form ....

333

1

3

999

Total ...........................................

...........................................................

........................

........................

........................

999

Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2021–11148 Filed 5–25–21; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day-21–0222; Docket No. CDC–2021–
0051]

Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:

The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled the Collaborating Center for
Questionnaire Design and Evaluation
Research (CCQDER). This generic
clearance request, requests approval for
collection of information that
encompasses general questionnaire
development, pre-testing, and
measurement-error reduction activities
to be carried out in 2021–2024.
DATES: CDC must receive written
comments on or before July 26, 2021.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2021–
0051 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
SUMMARY:

VerDate Sep<11>2014

20:22 May 25, 2021

Jkt 253001

Clifton Road NE, MS–D74, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS–
D74, Atlanta, Georgia 30329; phone:
404–639–7118; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected;

PO 00000

Frm 00029

Fmt 4703

Sfmt 4703

4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses; and
5. Assess information collection costs.
Proposed Project
The Collaborating Center for
Questionnaire Design and Evaluation
Research (CCQDER) (OMB Control No.
0920–0222, Exp. 08/31/2021)—
Revision—National Center for Health
Statistics (NCHS), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
Section 306 of the Public Health
Service (PHS) Act (42 U.S.C. 242k), as
amended, authorizes that the Secretary
of Health and Human Services (DHHS),
acting through NCHS, shall undertake
and support (by grant or contract)
research, demonstrations, and
evaluations respecting new or improved
methods for obtaining current data to
support statistical and epidemiological
activities for the purpose of improving
the effectiveness, efficiency, and quality
of health services in the United States.
The Collaborating Center for
Questionnaire Design and Evaluation
Research (CCQDER) is the focal point
within NCHS for questionnaire and
survey development, pre-testing, and
evaluation activities for CDC surveys
such as; the National Survey of Family
Growth (NSFG) (OMB Control No.
0920–0314), the Research and
Development Survey (RANDS),
including RANDS COVID (OMB Control
No. 0920–1298), and other federallysponsored surveys. The CCQDER is
requesting three additional years of
OMB Clearance for this generic
submission.
The CCQDER and other NCHS
programs conduct cognitive interviews,
focus groups, in-depth or ethnographic
interviews, usability tests, field tests/
pilot interviews, and experimental
research in laboratory and field settings,
both for applied questionnaire
development and evaluation, as well as

E:\FR\FM\26MYN1.SGM

26MYN1